Stem cells try the intranasal route; Salmonella prepped as delivery agent;

> Intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded  motor function improvement and a reversal of dopamine deficiency. Item

> UC Berkeley researchers have made a modified strain of Salmonella to deliver interfering RNA exactly where needed. Article

> The consultancy Technology Catalysts finds upside potential in parenteral depots via reformulation of marketed drugs, use as  an alternative pathway in drug development, and use as a competitive differentiator for biosimilars. Release

> Bioject Medical will supply its Intradermal Pen disposable-syringe jet injector, still under development, to WHO for clinical research of intradermal delivery of vaccines in developing-country immunization programs.

> Dispensers cut in half the likelihood of dosing mistakes with pills and capsules compared with non-dispenser administration in homes for the elderly. Article

> Alvogen has launched a nitroglycerin transdermal system boasting small patch sizes and RSS bar coding. Release

> Some drugmakers are giving needle-free injection technology a second look, thanks to improved device designs, patient sentiment, and new therapeutic applications. Release

And Finally... Elan Drug Technologies won the Pipeline Value Creation Award at the Drug Delivery Partnerships meeting last month; Zogenix won the Innovation Award. Release | Release

Suggested Articles

Armed with microrobots and magnetic fields, Pursue scientists are looking to the future of targeted drug delivery, starting with the colon.

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.